Skip to content

Docs (opens in a new tab)Pricing Research Benchmark

Sign in Sign up

P

PCRX

Pacira BioSciences, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$26.35

−0.94%

FinancialsValuationProfitabilityGrowthCapitalMomentum

EarningsOwnershipNewsAnalysis

Research · Sep 3, 2026

PCRX: FY25 Deep Dive

Pacira BioSciences FY25 at $726M. NI $7M; EPS $0.16.

The idea engine
for fundamental investors.

Product

Ask drillr Watchlist

Resources

Research Methodology Benchmark Docs (opens in a new tab)

Data parsed from primary filings: SEC EDGAR · EDINET · HKEX · CNINFO · DART. Prices delayed 15 minutes.

Pricing Privacy Terms© 2026 LIL GREBE INC.